Two new papers from/in collaboration with our group
Paper 1:
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
Paper 2:
Circulating Tumor Cell Persistence Associates with Long-TermClinical Outcome to a Therapeutic Cancer Vaccine inProstate Cancer
Ingrid Jenny Guldvik, Lina Ekseth, Amar U. Kishan, Andreas Stensvold, Else Marit Inderberg and Wolfgang Lilleby